✦ LIBER ✦

Outcome of Treatment With Pegylated Interferon and Ribavirin in Heart Transplant Recipients With Chronic Hepatitis C

✍ Scribed by E. Durante-Mangoni; E. Ragone; D. Pinto; D. Iossa; F.E. Covino; C. Maiello; R. Utili

Book ID: 113934901
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 695 KB
Volume: 43
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2010.09.096

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C with PE

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

✍ Markus Cornberg; Heiner Wedemeyer; Michael P. Manns 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 513 KB

Pilot study of treatment with pegylated

Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection

✍ B. Roche; A.M. Roque-Afonso; M. Sebagh; C. Feray; C. Guettier; E. Dussaix; D. Ca 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Hepatitis C and treatment with pegylated

Hepatitis C and treatment with pegylated interferon and ribavirin

✍ James Gotto; Geoffrey M Dusheiko 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Retinopathy associated with pegylated in

Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C

✍ Shelly Adams; Mark Ostermeier 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 995 KB

Pegylated interferons in combination wit

Pegylated interferons in combination with ribavirin for the treatment of chronic hepatitis C

✍ Markus Cornberg; Heiner Wedemeyer; Michael P. Manns 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 313 KB

Treatment of chronic hepatitis E in live

Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b

✍ Elizabeth B. Haagsma; Annelies Riezebos-Brilman; Arie P. van den Berg; Robert J. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

Hepatitis E virus (HEV) infections are known to run a self-limiting course. Recently, chronic hepatitis E has been described in immunosuppressed patients after solid-organ transplantation. Besides the general recommendation to lower the immunosuppressive medication in these patients, there is curren